MYX mayne pharma group limited

Ann: NEXTSTELLIS oral contraceptive now available in Australia, page-3

  1. 1,840 Posts.
    lightbulb Created with Sketch. 38
    "NEXTSTELLIS will compete in the Australian combined (estrogen plus progestin) oral contraceptive market which is valued at A$60 million."

    Thought that the market would have been bigger than this. I mean realistically how much of that market can we actually take a share of and how long is it going to take to get there. Hopefully this will fair better in the states than in AU.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.95
Change
-0.200(3.88%)
Mkt cap ! $402.1M
Open High Low Value Volume
$5.05 $5.09 $4.93 $824.9K 165.3K

Buyers (Bids)

No. Vol. Price($)
1 16429 $4.95
 

Sellers (Offers)

Price($) Vol. No.
$5.08 5000 1
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.